Predictive Biomarker Testing in Colorectal Cancer: KRAS and BRAF Mutation Frequency and Testing Algorithm in Developing Countries

Predictive biomarker testing is mandatory before initiating targeted therapy in metastatic colorectal cancer (mCRC). Mutation frequencies and their association with clinicopathological features vary widely across populations. In low socio-economic countries, appropriate selection of cases is important for biomarker testing....

Author : Niraj Kumari, Narendra Krishnani, Ashok Kumar, Balraj Mittal
Keyword : metastatic colorectal cancer, kras, braf, predictive biomarker, anti-egfr
Category : Original Articles